Target- |
MechanismCell wall inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date25 Oct 2024 |
100 Clinical Results associated with Iterum Therapeutics US Ltd.
0 Patents (Medical) associated with Iterum Therapeutics US Ltd.
100 Deals associated with Iterum Therapeutics US Ltd.
100 Translational Medicine associated with Iterum Therapeutics US Ltd.